Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .
NCT06632522
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Interventions
DRUG:
radiotherapy combined with Camrelizumab and Apatinib
Sponsor
Beijing Tsinghua Chang Gung Hospital